Join
Live feed
·
SECFilingvia Quantisnow
Keros Therapeutics Inc. logo

Amendment: SEC Form SCHEDULE 13G/A filed by Keros Therapeutics Inc.

ByQuantisnow·Wall Street's wire, on your screen.
KROS· Keros Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KROS (Keros Therapeutics Inc.) and more on Quantisnow.

Amendment: SEC Form SCHEDULE 13G/A filed by Keros Therapeutics Inc. | Quantisnow